Related Experiment Video

Updated: Jan 10, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

739

MicroRNAs in esophageal cancer (review)

Bin He1, Bangliang Yin, Baoxiang Wang

  • 1Department of Cardiothoracic Surgery, the Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, PR China.

Molecular Medicine Reports
|July 4, 2012
PubMed

Insights

Esophageal cancer (EC) survival rates are poor due to late diagnosis. MicroRNAs (miRNAs) are key regulators of gene expression implicated in EC development and progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Esophageal cancer (EC) is a prevalent malignancy with a poor prognosis, often diagnosed at advanced stages.
  • Current treatments yield limited long-term survival rates, highlighting the need for novel therapeutic targets.
  • MicroRNAs (miRNAs), small non-coding RNAs, are increasingly recognized for their role in gene regulation and cancer biology.

Purpose of the Study:

  • To review recent findings on miRNA expression in EC.
  • To elucidate the impact of deregulated miRNAs on EC biology.
  • To explore the potential of miRNAs as diagnostic and therapeutic biomarkers for EC.

Main Methods:

  • Literature review of studies investigating miRNA expression in esophageal cancer.
  • Analysis of miRNA's role in EC initiation, progression, and metastasis.
  • Evaluation of current and emerging applications of miRNAs in EC management.

Main Results:

  • MicroRNA expression is frequently altered in EC tissues compared to normal tissues.
  • Deregulation of specific miRNAs contributes to EC tumorigenesis and progression.
  • miRNAs show promise as biomarkers for early detection and as therapeutic targets.

Conclusions:

  • MicroRNAs play a critical role in the development and progression of esophageal cancer.
  • Understanding miRNA dysregulation offers new avenues for improving EC diagnosis and treatment.
  • Targeting miRNAs represents a promising strategy for future EC therapies.

More Related Videos

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids10:43

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Published on: December 23, 2022

3.9K
Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool08:49

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

11.6K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K